TGFB1 and neoplasm: Recent approaches aiming at reprogramming of the tumor-microenvironment (TME) by either targeting cancer-associated fibroblast mediated immune evasion (8) or TGFβ signaling, may enhance (immune)-therapy (9), improve vaccine approaches (10) or chemotherapy (11).